checkAd
    Startseite > Aktien > Humacyte > Nachrichten
    Humacyte Aktie
    6,3300
     
    USD
    -1,40 %
    -0,0900 USD
    Letzter Kurs 02:00:00 Nasdaq
    6,3200
     
    USD
    6.800 STK
    Geldkurs 17.05.24
    6,3300
     
    USD
    800 STK
    Briefkurs 17.05.24
    ISIN: US44486Q1031 · WKN: A3CZBW · SYM: HUMA · USA

    Neueste Nachrichten

    Humacyte to Participate at Upcoming Investor Conferences in May
    13.05.24 · globenewswire · Humacyte
    Humacyte First Quarter 2024 Financial Results and Business Update
    10.05.24 · globenewswire · Humacyte
    Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 10, 2024
    06.05.24 · globenewswire · Humacyte
    Humacyte to Host Virtual KOL Event “Hemodialysis Access: A Crossroads of Care,” on March 28, 2024
    26.03.24 · globenewswire · Humacyte
    Humacyte Fourth Quarter and Year End 2023 Financial Results and Business Update
    22.03.24 · globenewswire · Humacyte
    Humacyte to Present 2023 Fourth Quarter and Year-End Financial Results and Provide Corporate Update on March 22, 2024
    18.03.24 · globenewswire · Humacyte
    Humacyte, Inc. to Present at the TD Cowen 44th Annual Health Care Conference
    01.03.24 · globenewswire · Humacyte
    Humacyte, Inc. Announces Pricing of $40.2 Million Public Offering of Common Stock
    01.03.24 · globenewswire · Humacyte
    Humacyte, Inc. Announces Proposed Public Offering of Common Stock
    29.02.24 · globenewswire · Humacyte
    Human Acellular Vessel (HAV) Biologics License Application Granted Priority Review by U.S. FDA for the Treatment of Vascular Trauma
    09.02.24 · globenewswire · Humacyte
    Humacyte to Present at the Piper Sandler 35th Annual Healthcare Conference
    24.11.23 · globenewswire · Humacyte
    Humacyte Announces Two Presentations at the VEITHsymposium of Positive Clinical Results of the Human Acellular Vessel (HAV) in the Treatment of Vascular Trauma
    17.11.23 · globenewswire · Humacyte